Home › COVID-19 and Coronavirus Infections › North Carolina
COVID-19 and Coronavirus Infections clinical trials in North Carolina
5 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in North Carolina.
Cities in North Carolina
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Durham
- Research Site, Winston-Salem
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Duke Vaccine and Trials Unit, Durham
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 64 · All sexes · Updated Aug 7, 2026 · NCT07730450Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Duke University, Durham
RecruitingPhase 3
All ages · All sexes · Updated Jun 23, 2026 · NCT03808922From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.